Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Alta Equipment A Pref | ALTG-A | Oct 31, 2024 | 25.53 | -0.74 |
Alta Equipment Group A | ALTG | Oct 31, 2024 | 6.50 | -0.46 |
Alta Global Group | MMA | Oct 31, 2024 | 2.41 | -0.76 |
Altair Engineering A | ALTR | Oct 31, 2024 | 103.99 | -4.27 |
Altamira Therapeutics | CYTO | Oct 31, 2024 | 0.48 | +0.68 |
AltEnergy Acquisition A | AEAE | Oct 31, 2024 | 11.22 | 0.00 |
AltEnergy Acquisition Unit | AEAEU | Oct 31, 2024 | 11.30 | 0.00 |
Alterity Therapeutics ADR | ATHE | Oct 31, 2024 | 1.15 | -2.19 |
Alternus Clean Energy A | ALCE | Oct 31, 2024 | 2.42 | -11.19 |
Alti Global A | ALTI | Oct 31, 2024 | 4.08 | -0.49 |
Altice USA A | ATUS | Oct 31, 2024 | 2.43 | -3.57 |
Altimmune | ALT | Oct 31, 2024 | 6.74 | -0.30 |
Altisource Portfolio Solutions | ASPS | Oct 31, 2024 | 1.21 | +2.54 |
Alto Ingredients | ALTO | Oct 31, 2024 | 1.78 | +3.49 |
Alto Neuroscience | ANRO | Oct 31, 2024 | 3.89 | -3.47 |
Altria Group | MO | Oct 31, 2024 | 54.46 | +7.84 |
Altus Power A | AMPS | Oct 31, 2024 | 3.44 | -4.18 |
Alumis | ALMS | Oct 31, 2024 | 11.32 | +0.80 |
Alvotech | ALVO | Oct 31, 2024 | 12.98 | +1.64 |
ALX Oncology | ALXO | Oct 31, 2024 | 1.43 | +3.62 |
Alzamend Neuro | ALZN | Oct 31, 2024 | 1.57 | +0.64 |
Amalgamated Financial | AMAL | Oct 31, 2024 | 33.16 | -1.06 |
Amarin ADR | AMRN | Oct 31, 2024 | 0.58 | -3.74 |
Amazon.com | AMZN | Oct 31, 2024 | 186.40 | -3.28 |
Ambac Financial Group | AMBC | Oct 31, 2024 | 11.31 | -1.65 |
Ambarella | AMBA | Oct 31, 2024 | 56.19 | -5.12 |
Ambev ADR | ABEV | Oct 31, 2024 | 2.18 | -3.96 |
Ambipar Emergency Response | AMBI | Oct 31, 2024 | 6.23 | -5.18 |
Ambow Education A ADR | AMBO | Oct 31, 2024 | 1.60 | -1.84 |
AMC Entertainment A | AMC | Oct 31, 2024 | 4.39 | -3.73 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.